Effect of feeding thyrotropin-releasing hormone to lactating sows.
Two experiments were conducted to assess the effects of feeding thyrotropin-releasing hormone (TRH) during lactation on sows. In Exp. 1, sows were fed 0, 1, 10, 100 or 1,000 mg TRH on d 10.8 +/- .4 (mean +/- SE) after parturition. Blood samples were taken from sows every 30 min from -2 h to 8 h and at 10, 12 and 18 h from feeding. Consumption of 100 or 1,000 mg TRH increased mean serum concentrations of thyroxine (T4; P less than .001), 1,000 mg TRH increased growth hormone (GH; P less than .06) and 100 or 1,000 mg TRH increased prolactin (PRL; P less than .01), but insulin (INS; P greater than .10) was unaffected by TRH. Serum concentrations of T4 were elevated within 2 to 4 h after feeding TRH and remained elevated for 12 to 18 h. Concentrations of GH and PRL began to increase immediately after feeding 100 or 1,000 mg TRH and remained elevated for 6 and 8 h, respectively. In Exp. 2, sows were fed 0 or 200 mg TRH from d 111 of gestation to weaning at 27.1 +/- .3 d of lactation. Consumption of TRH elevated concentrations of T4 at all stages of lactation and increased respiration rate on d 10 and d 20, heart rate on d 20, and milk production on d 20 of lactation. Consumption of TRH did not influence number of pigs born, number born alive, survival rate during lactation, sow body weight, heartgirth, backfat depth, feed disappearance, or milk production on d 10 of lactation. Piglets nursing sows fed TRH were similar in weight to piglets nursing sows not fed TRH on d 0 and 5 of lactation, but they were heavier on d 10 (P less than .07), 15 (P less than .001), 20 (P less than .001) and 27 (P less than .0001). Sows fed TRH took longer (P less than .001) to return to estrus after weaning than control sows. Results indicated that feeding TRH elevated T4, GH and PRL and that feeding TRH for the duration of lactation increased milk production on d 20 of lactation and increased weaning weights, but it delayed estrus after weaning.
Cabell
S B
SB
Dept. of Anim. Sci., North Carolina State University, Raleigh 27695-7621.
Esbenshade
K L
KL
D000284:Administration, Oral; D000818:Animals; D000833:Animals, Suckling / Q000254:growth & development; D001835:Body Weight / Q000187:drug effects; D004971:Estrus / Q000187:drug effects; D005260:Female; D013006:Growth Hormone / Q000097:blood; D006339:Heart Rate / Q000187:drug effects; D007328:Insulin / Q000097:blood; D007774:Lactation / Q000187:drug effects*; D011247:Pregnancy; D011388:Prolactin / Q000097:blood; D012119:Respiration / Q000187:drug effects; D013552:Swine / Q000254:growth & development / Q000378:metabolism* / Q000502:physiology; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*; D013974:Thyroxine / Q000097:blood
D007328:Insulin; D013973:Thyrotropin-Releasing Hormone; D011388:Prolactin; D013006:Growth Hormone; D013974:Thyroxine